Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Cancer: Page 2
Spectrum Healthcare Partners adopts Proscia digital pathology platform
The addition of Proscia's Concentriq Dx digital platform will allow Spectrum Healthcare Partners to expand the reach of its experts across the healthcare systems it serves in Maine and New Hampshire.
March 13, 2023
At USCAP 2023, ProPhase Labs to present data about esophageal cancer screening test
The upcoming presentation in New Orleans is scheduled for March 14 and entitled "Targeted Mass Spectrometry of Barrett's Esophagus Reveals High-Fidelity Combinatorial Molecular Correlates."
March 13, 2023
PathAI announces adoption of digital pathology products by anatomic pathology laboratories
A network of laboratories will be the first to access PathAI's growing menu of algorithm products for oncology and non-oncology indications.
March 9, 2023
Mindpeak AI algorithms for IHC available on Paige pathology platform
The firms combined their technologies to help pathologists deliver fast, accurate, and reproducible quantitative cancer diagnoses, even in the most challenging and complex cases, Paige said.
March 9, 2023
Alverno Laboratories to expand Ibex’s AI-powered cancer diagnostics suite throughout its Midwest network
Alverno, among the first U.S. laboratory networks to digitize its pathology services, is also the first to offer the Ibex AI-supported cancer diagnostic service in the U.S.
March 9, 2023
Protein expression biomarker may identify likely responders to potential breast cancer drug
In a study, researchers sought to understand the value of RANK and RANKL protein expression as a predictor of breast cancer outcomes and as a therapeutic target.
March 8, 2023
DermTech obtains melanoma testing coverage for additional 1.9 million people
The skin-based genomics test is a noninvasive way to enhance melanoma detection with a greater than 99% negative predictive value, DermTech said.
March 7, 2023
AACC provides recommendations for detecting cervical cancer
The guidance aims to update healthcare and laboratory medicine professionals about the latest advancements in this field, and to help them select the most effective cervical cancer detection strategy for their patients, AACC said.
March 6, 2023
Active surveillance on the rise for low-risk prostate cancer
A large study indicates that active surveillance rates for management of low-risk prostate cancer are rising nationally, but are still not optimal.
March 2, 2023
Natera receives commercial payor coverage for molecular residual disease test
Among the first commercial coverage policies for the test, Blue Shield of California began providing coverage of Signatera for plan members diagnosed with solid tumors.
March 2, 2023
Bio-Techne's prostate test granted expanded Medicare coverage
The updated Medicare policy covers an annual ExoDx Prostate Test for men who have already had a negative biopsy but are thought to be at high risk for prostate cancer and are considering a repeat biopsy.
February 24, 2023
Missed cancer screenings continue during pandemic’s second year
The COVID-19 pandemic disrupted the delivery and receipt of many routine preventive services, including important cancer screenings that might help prevent and catch cancer at its earliest stages, when it is often easiest to treat.
February 24, 2023
Previous Page
Page 2 of 81
Next Page